logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
✓7-day trial • $39/mo or $29/mo annual
✓AI + proprietary hiring database
✓Executive contact details included
INDUSTRY FIRST

Ascendis Welcomes Yann Berube As Head of Technology Implementation After Merging With Pencilz Labs

Jun 03, 2024•about 1 year ago

Position

Head of Technology Implementation

Company

Ascendis

Yann Berube
MontrealConsulting

Description

Ascendis, a strategy, design, and technology firm, has announced its merger with Pencilz Labs, a digital design, development, and creative group. As part of the merger, Yann Berube, the founder of Pencilz Labs, will join Ascendis as the head of technology implementation, strengthening the company's digital transformation services.

Company Information

Company

Ascendis

Location

Montreal, Quebec, Canada

About

Established in 2015, Ascendis is a full-service strategy, design, and technology firm with offices in Montreal and Toronto. It has successfully advised over 400 fast-growing companies across a broad range of industries. The Ascendis mission is to empower bold leaders to grow their businesses by developing forward-thinking strategies and create products, services, and experiences people love. With a world-class team combining strategic consulting with human-centered design and extensive technological expertise, Ascendis is equipped to help clients transform their businesses–from strategy to execution.

Company News

(10 articles)
Mon, 12 May 2025 07:00:00 GMT

Ascendis Pharma Announces Long-Term Phase 2 Trial Data Demonstrating Sustained Efficacy and Safety of TransCon PTH in Adults with Hypoparathyroidism - Nasdaq

Wed, 12 Feb 2025 08:00:00 GMT

Ascendis Pharma opens new office for the UK and Ireland - European Pharmaceutical Manufacturer

Mon, 13 Jan 2025 08:00:00 GMT

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court - PR Newswire

Tue, 13 May 2025 07:00:00 GMT

New Data Shows Improvements in Growth and Bone Morphometry - GlobeNewswire

Mon, 03 Jun 2024 07:00:00 GMT

Ascendis Consulting Accelerates Growth with Pencilz Labs Merger - PRWeb

Mon, 12 Aug 2024 07:00:00 GMT

FDA approves Ascendis drug for rare endocrine condition - BioPharma Dive

Mon, 12 Aug 2024 07:00:00 GMT

Ascendis scores hard-fought FDA nod for hormone replacement therapy Yorvipath - Fierce Pharma

Fri, 06 Dec 2024 08:00:00 GMT

Ascendis Pharma Selects PANTHERx® Rare for the Distribution of YORVIPATH® (palopegteriparatide) - PR Newswire

Mon, 29 Jan 2024 08:00:00 GMT

Ascendis spins out new ophthalmology biotech Eyconis, gaining equity and biobucks - Fierce Biotech

Tue, 27 Feb 2024 08:00:00 GMT

PB Swiss Tools and Ascendis Partner to Launch Direct-to-Consumer Channel in the USA - PRWeb

FundzWatch™ Score

6
Low Activity
1 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months